Saxenda 1
Saxenda 1
Saxenda 1
Getting support from a weight-loss program Measuring success by having better eating
or a group habits
What is Saxenda®?
Saxenda® (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who
also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132
pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced calorie
diet and increased physical activity.
• Saxenda® and Victoza® have the same active ingredient, liraglutide, and should not be used together or with other GLP-1
receptor agonist medicines
• It is not known if Saxenda® is safe and effective when taken with other prescription, over-the-counter medicines, or herbal
weight-loss products
• It is not known if Saxenda® is safe and effective in children under 12 years of age
• It is not known if Saxenda® is safe and effective in children aged 12 to 17 years with type 2 diabetes
Please see additional Important Safety Information, including Boxed Warning, throughout.
Please see Prescribing Information and Medication Guide for Saxenda® available at Saxenda.com.
About Me
BMI is a measurement that helps health care providers determine whether a person is carrying excess
My body mass index (BMI) is
weight in relation to his or her height. The standard categories of BMI ranges are
Below 18.5 = underweight 25.0 to 29.9 = overweight
35.5 18.5 to 24.9 = healthy weight 30.0 or above = obese
I have had some success with better eating habits I have a good support system
I have tried to lose weight in the past year I am willing to consider injections
Please see additional Important Safety Information, including Boxed Warning, throughout.
Please see Prescribing Information and Medication Guide for Saxenda® available at Saxenda.com.
Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.